AgMedica Bioscience Inc. Announces Strategic Alliance with Nutrasource Pharmaceutical and Nutraceutical Services

AgMedica Bioscience Inc., a licensed producer of medicinal cannabis, is pleased to announce that the Company has entered into a strategic alliance with Nutrasource Pharmaceutical and Nutraceutical Services, a contract research organization specializing in the provision of global regulatory, clinical trial design and execution, as well as analytical and bio-analytical testing, all of which represent key components for the successful commercialization of health products. The Alliance ideally positions AgMedica to clinically validate the numerous cannabis-derived medicines and health products being developed based on the Company’s global intellectual property, strategic partnerships and international joint ventures.

NutraSource brings a seasoned and proven approach to research and development, coupled with exceptional clinical trial design and implementation. Through the Alliance, AgMedica and its industry partners will have access to NutraSource’s expertise in generating evidence-based claims substantiation for products, a critical requirement for global regulatory approval, acceptance by the medical community and adoption by consumers. With competent and reliable scientific evidence of product claims, doctors and health practitioners are afforded the required information and confidence to recommend and prescribe cannabis-derived medicines and health products to target the treatment of specific conditions.

“We are very pleased to enter into this important strategic alliance with NutraSource, whose approach, culture and values are optimally aligned with AgMedica’s, as we aim to accelerate our ultimate goal of commercializing and providing access to differentiated cannabis products for the medicinal, pharmaceuticaland health and wellness sectors,” said Dr. Trevor Henry, CEO of AGMEDICA. “Our relationship with NUTRASOURCE is expected to help AGMEDICA bring new cannabis products to market with trust and confidence, backed by strong science and regulatory credibility.”